# Efficacy and Safety of MC2-25 Cream & Vehicle in Women With Vulvar Lichen Sclerosus (VLS)

> **NCT06132919** · PHASE2 · COMPLETED · sponsor: **MC2 Therapeutics** · enrollment: 33 (actual)

## Conditions studied

- Vulvar Lichen Sclerosus

## Interventions

- **DRUG:** MC2-25 cream
- **DRUG:** MC2-25 vehicle

## Key facts

- **NCT ID:** NCT06132919
- **Lead sponsor:** MC2 Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-11
- **Primary completion:** 2024-11-08
- **Final completion:** 2024-11-08
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2025-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06132919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06132919, "Efficacy and Safety of MC2-25 Cream & Vehicle in Women With Vulvar Lichen Sclerosus (VLS)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06132919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*